Back
Tenax Therapeutics 10K Form
Sell
13
TENX
Tenax Therapeutics
Last Price:
3.47
Seasonality Move:
-8.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TENX News And Ratings
See the #1 stock for the next 7 days that we like better than TENX
TENX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-5.17M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.35 |
| Price / Book: | 0.55 |
Profitability
| EPS (TTM): | -25.36000 |
|---|---|
| Net Income (TTM): | $-10.1M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Tenax Therapeutics Earnings Forecast
Key Tenax Therapeutics Financial Ratios
- The Interest Expense is -0.31% of Operating Income.
- Per Share Earnings over the last 28 years have been positive in 18 years.
Tenax Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TENX |
| CUSIP: | 88032L |
| Website: | tenaxthera.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TENX Technical Analysis vs Fundamental Analysis
Sell
13
Tenax Therapeutics (TENX)
is a Sell
Is Tenax Therapeutics a Buy or a Sell?
-
Tenax Therapeutics stock is rated a Sell
The current Tenax Therapeutics [TENX] share price is $3.46. The Score for TENX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.